# LLM call: summary

- Turn: 10
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 730
- Completion tokens: 418
- Total tokens: 1261
- Cost (USD): 0.000158

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1535: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Through 2030 the Shield stalemate persisted: Brussels offered no new money or chips, pushing lithography servicing/spares tied to pooled compute and anchored builds in Japan, Korea, Singapore. Upstream Bargain concluded negotiation phase with reciprocal queue-mapping and test-sharing, but strait shut, no hardware moved, Gulf capacity absorbed at home. Anchorage Pact gave legal base only. Ratification inched forward without volume guarantees.

Second half brought foreign-model medical breakthrough — tailored cancer and rare-disease therapies trialled in US hospitals. Brussels deployed via health authorities/emergency body to certified cyber-recovered hospitals in a dozen university centres; procurement favoured European-anchored queues with health-data rules/signatures, but dosing/variant-tuning still depended on American cloud, pharmacists reverted when queues stalled.

Foreign robots entered logistics at Rotterdam, Antwerp, Lodz — Chinese machines on American control software, cutting agency shifts, Lille pickets. Commission added no instrument, only extended ENISA segmentation guides via industry directorate; Paris/Berlin warned automation on чужой stack.

US-leaving talent held chairs/EuroHPC posts but queued large runs on older nodes; no open-weight frontier release reached Europe. Cyber recovery partial, insurers raised premiums, separate-cloud capital stayed outside. Net public mood ticked up on cures, legitimacy barely held, sovereignty only slightly up on legal base without silicon.

CURRENT NARRATIVE:
### The audit that worked
Early in the year a control result out of the leading labs changed the safety conversation. Not a paper promise but testable checks on models already in hospitals and warehouses — behaviour that could be predicted and certified rather than argued over. Because the labs wanted it too, adoption was fast.

Brussels, with almost no money to spend, moved quickly to make it European. The AI Office and the Joint Research Centre issued certified harnesses for the dosing and variant-tuning models used in the dozen university cancer centres, and added segmentation checks for the warehouse control software spreading around Rotterdam, Antwerp and Lodz. Procurement preference went to models that passed. Doctors noticed fewer queue stalls and fewer quiet reversions to the American cloud; logistics operators grumbled about paperwork but passed audits.

It did not solve dependence. Dosing still leaned on foreign frontier models, robots still ran on imported machines and foreign software, and the strait closure kept Japanese, Korean and Singaporean hardware from moving. The lithography-for-compute bargain stayed legal paper, and landed researchers still queued on older EuroHPC nodes.

### Offices, not picket lines
The other shift came from ordinary offices. Law firms, accountancies, administrations and newsrooms reported measured gains — juniors drafting faster, seniors spending days on judgement rather than formatting. Firms that had cut headcount early quietly hired again. With no displacement wave to point at, unions struggled to mobilise beyond Lille, and opposition to data centres softened.

The trusted medical deployment finished its rollout phase, putting tailored therapies into regular use in certified hospitals. Families got cures, ministers got photos, insurers got higher premiums for the still-partially recovered systems.

Legitimacy rebuilt a little. Sovereignty did not.
```

## Raw response

```
Through 2030 Shield stalemate persisted: Brussels offered no new money/chips, pushing lithography servicing tied to pooled compute and anchored builds in Japan/Korea/Singapore. Upstream Bargain stayed negotiation-paper with strait shut, no hardware moved. Anchorage Pact gave legal base only. Foreign-model medical therapies trialled in US hospitals then deployed via Brussels to a dozen certified cyber-recovered university centres, but dosing/variant-tuning depended on American cloud with reversions when queues stalled. Chinese robots on American software entered Rotterdam/Antwerp/Lodz logistics, cutting shifts, Lille pickets; Commission added only ENISA guides. US-leaving talent held chairs but queued on older EuroHPC nodes; cyber recovery partial, premiums up.

Early next year testable control/certification results from leading labs changed safety debate. With labs cooperating, AI Office and JRC issued certified harnesses for hospital dosing/variant-tuning models and segmentation checks for warehouse control software; procurement favoured passing models. Queue stalls and quiet reversions to US cloud fell; operators passed audits despite paperwork. Dependence unsolved: foreign frontier models, imported machines/software, strait still closed.

Ordinary offices reported measured AI productivity gains — juniors drafting faster, early cutters rehiring — blunting displacement fears, weakening union mobilisation beyond Lille and softening data-centre opposition. Tailored therapies moved into regular use in certified hospitals. Legitimacy rebuilt slightly; sovereignty did not.
```
